Qian Liu; Pengfei Jin; Jingxin Li; Xiaoqin Chen; Chenhao Wang; Qingbin Lu; Wei Jiang; Shixuan Zhang; Lairun Jin; Hongxin Pan; Xue Guo; Fengcai Zhu; Qian Liu; Pengfei Jin; Jingxin Li; Xiaoqin Chen; Chenhao Wang; Qingbin Lu; Wei Jiang; Shixuan Zhang; Lairun Jin; Hongxin Pan; Xue Guo; Fengcai Zhu

doi:10.46234/ccdcw2024.082

[1]

Sreenivasan CC, Thomas M, Antony L, Wormstadt T, Hildreth MB, Wang D, et al. Development and characterization of swine primary respiratory epithelial cells and their susceptibility to infection by four influenza virus types. Virology 2019;528:152 − 63. https://doi.org/10.1016/j.virol.2018.12.016.

[2]

Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 2018;391(10127):1285 − 300. https://doi.org/10.1016/S0140-6736(17)33293-2.

[3]

Gong H, Shen X, Yan H, Lu WY, Zhong GJ, Dong KG, et al. Estimating the disease burden of seasonal influenza in China, 2006-2019. Natl Med J China 2021;101(8):560 − 7. https://doi.org/10.3760/cma.j.cn112137-20201210-03323.

[4]

Moritzky SA, Richards KA, Glover MA, Krammer F, Chaves FA, Topham DJ, et al. The negative effect of preexisting immunity on influenza vaccine responses transcends the impact of vaccine formulation type and vaccination history. J Infect Dis 2023;227(3):381 − 90. https://doi.org/10.1093/infdis/jiac068.

[5]

Matrajt L, Britton T, Halloran ME, Longini IM Jr. One versus two doses: what is the best use of vaccine in an influenza pandemic? Epidemics 2015;13:17-27. http://dx.doi.org/10.1016/j.epidem.2015.06.001.

[6]

Scheifele DW, Ward BJ, Dionne M, Vanderkooi O, Langley JM, Dobson S, et al. Evaluation of adjuvanted pandemic H1N1₂₀₀₉ influenza vaccine after one and two doses in young children. Pediatr Infect Dis J 2011;30(5):402 − 7. https://doi.org/10.1097/INF.0b013e3182068f33.

[7]

Neuzil KM, Jackson LA, Nelson J, Klimov A, Cox N, Bridges CB, et al. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis 2006;194(8):1032 − 9. https://doi.org/10.1086/507309.

[8]

Yu L, Gao JX, Lei M, Li N, Ruan CL, Jian Z, et al. Immunogenicity and safety levels of inactivated quadrivalent influenza vaccine in healthy adults via meta-analysis. Hum Vaccin Immunother 2021;17(10):3652 − 61. https://doi.org/10.1080/21645515.2021.1932218.

[9]

Kelvin AA, Zambon M. Influenza imprinting in childhood and the influence on vaccine response later in life. Euro Surveill 2019;24(48):1900720. https://doi.org/10.2807/1560-7917.ES.2019.24.48.1900720.